blockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Popular
Elections

Genius — OpenServe

Sponsored

FibroGen (United States) — latest news, discussion & facts — IJR

FibroGen (United States)

Organization

FibroGen (United States)

company in San Francisco, United States

0members1here now

Ask Genius Site

Feed Discussions About

Sort by

Content type

Loading

Latest FibroGen (United States) news and discussion

Sort by

Content type

Nothing published yet

The conversation starts anyway — post the first discussion above.

About FibroGen (United States)

Kyntra Bio, Inc. is a biopharmaceutical company headquartered in San Francisco, California. Once regarded as a promising developer of innovative therapies for anemia and fibrotic diseases, with a market capitalization of roughly $4 billion in 2018–19, the company's value collapsed following late-stage trial failures, regulatory setbacks, and a data manipulation scandal. By 2026, Kyntra was mainly reduced to a single early-stage oncology drug candidate.

0

members

1

here now

Country: United States
Headquarters

Facts from Wikidata (CC0).

San Francisco

Inception

January 1, 1993

Website

http://www.fibrogen.com/

Everything about FibroGen (United States) →

Live room · 1 here

Be the first in the room — members see you arrive.

FibroGen (United States) across IJR

Ask Genius by OpenServe about FibroGen (United States)Create in Studio Build a game Watch videos